Melanomas excised in primary care vs secondary care excision

  • Research type

    Research Study

  • Full title

    Do melanomas excised in primary care have different outcomes to those excised in secondary care?

  • IRAS ID

    183757

  • Contact name

    Peter Murchie

  • Contact email

    p.murchie@abdn.ac.uk

  • Sponsor organisation

    University of Aberdeen

  • Duration of Study in the UK

    1 years, 0 months, 1 days

  • Research summary

    Melanoma is a dangerous skin cancer, increasingly common due to increased foreign holidays and sun-bed use. Melanoma usually begins as a new or changing mole. Diagnosed quickly it can be removed in a simple operation and effectively cured. GPs can do this operation and many are highly skilled in minor surgery. However, guidelines written by specialists insist that all patients who might have a melanoma should be referred to hospital.
    People are becoming more skin aware and GPs are checking moles much more often. Sensibly many of these patients are being sent to hospital for a check, although most will not have melanoma.
    As a result hospital skin clinics are very busy and waiting times are increasing.
    People who do have a melanoma that is not clinically obvious are waiting an increasingly long time to have it diagnosed and treated in hospital, and this could actually mean that melanoma has more chance to spread while they wait.
    We conducted studies on 1200 people with a melanoma in Northeast Scotland between 1991 and 2008 finding that 20% of these people had their melanoma diagnosed and treated by their GP. These patients were no more likely to receive improper treatment than those referred to hospital. People who had their melanoma removed by a GP were no more likely to die from melanoma, and required fewer hospital visits afterward suggesting that the guidelines could be changed to allow GPs to treat suspicious moles. This would be better for patients and the NHS.
    However, we cannot recommend changes to the guidelines on the basis of local research therefore we wish to extend our study using data from 18,000 patients with melanoma from across Scotland. The results of this study will inform how the health service should deal with suspicious moles in the future.

  • REC name

    London - Surrey Research Ethics Committee

  • REC reference

    15/LO/1385

  • Date of REC Opinion

    4 Aug 2015

  • REC opinion

    Favourable Opinion